Micro Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ESCITALOPRAM OXALATE USP, with a corresponding US DMF Number 34568.
Remarkably, this DMF maintains an Active status since its submission on November 30, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 19, 2021, and payment made on December 11, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II